# Namenda (Memantine) for Non-motor Symptoms in Parkinson's Disease

> **NCT00646204** · PHASE4 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 40 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Memantine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00646204
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2009-02
- **Final completion:** 2009-03
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00646204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00646204, "Namenda (Memantine) for Non-motor Symptoms in Parkinson's Disease". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00646204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*